What effect would 25 mg of atenolol (beta-blocker) have on a heart rate of 94 beats per minute (tachycardia)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Effect of 25 mg Atenolol on Heart Rate of 94 bpm

Atenolol 25 mg would reduce a heart rate of 94 bpm by approximately 15-20 beats per minute within 2-4 hours of administration, with effects persisting for at least 24 hours.

Mechanism of Action and Pharmacodynamics

  • Atenolol is a beta1-selective (cardioselective) beta-adrenergic receptor blocking agent that reduces heart rate by blocking catecholamine effects on cardiac adrenergic receptors 1
  • The drug demonstrates a significant beta-blocking effect within one hour of oral administration, with maximal effect occurring at 2-4 hours post-dose 1
  • Beta-blockers reduce heart rate by: (1) reducing resting and exercise heart rate, (2) reducing cardiac output, (3) inhibiting isoproterenol-induced tachycardia, and (4) reducing reflex orthostatic tachycardia 1

Expected Heart Rate Reduction

  • For a heart rate of 94 bpm (mild tachycardia), 25 mg of atenolol would be expected to reduce the heart rate by approximately 15-20 bpm, bringing it to approximately 74-79 bpm 2, 3
  • Studies have shown that even low doses of atenolol (25 mg) produce significant reductions in exercise tachycardia, with greater reductions seen at higher doses 3
  • The heart rate-lowering effect of atenolol is dose-dependent, with 25 mg being the typical starting dose for rate control 4

Timing and Duration of Effect

  • The onset of action begins within 1 hour of oral administration 1
  • Peak effect occurs between 2-4 hours after ingestion 1
  • The beta-blocking activity of even a single 25 mg dose persists for at least 24 hours, making it suitable for once-daily dosing 1, 5
  • The elimination half-life of oral atenolol is approximately 6-7 hours 1

Clinical Considerations for Rate Control

  • Atenolol is indicated for control of ventricular rate in patients with atrial fibrillation or other supraventricular tachycardias 4
  • For rate control in tachyarrhythmias, the typical starting dose is 25-50 mg daily, which can be titrated up to 100 mg daily if needed 4
  • Atenolol has been shown to effectively prevent or control supraventricular tachycardias in approximately 68% of cases 6

Potential Side Effects and Precautions

  • Common side effects include hypotension, bradycardia, heart block, and worsening of heart failure 4
  • Atenolol should be used with caution in patients with:
    • AV block greater than first degree or SA node dysfunction (in absence of pacemaker) 4
    • Decompensated systolic heart failure 4
    • Reactive airway disease (though atenolol is more cardioselective than non-selective beta blockers) 1
    • Severe renal dysfunction (dose adjustment required) 1

Comparison with Other Beta Blockers

  • Atenolol has a longer duration of action compared to metoprolol, making it more suitable for once-daily dosing 3, 5
  • In comparative studies, atenolol 100 mg provided more effective blood pressure and heart rate reduction at 25 hours post-dose than metoprolol 100 mg 5
  • Atenolol is more cardioselective at lower doses compared to non-selective beta blockers like propranolol 1

In summary, 25 mg of atenolol would effectively reduce a heart rate of 94 bpm to a normal range within a few hours of administration, with the effect persisting for at least 24 hours. This makes it an appropriate choice for rate control in patients with mild tachycardia.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.